Message Font: Serif | Sans-Serif
No. of Recommendations: 7
I couldn't help but notice that Regeneron recently received FDA approval of Arcalyst (rilonacept) for CAPS. Good to see there are people working on this.

Note: Cryopyrin-Associated Periodic Syndromes (CAPS), a group of rare, inherited, auto-inflammatory conditions characterized by life-long symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue; and Motley Fool CAPS are not necessarily indications that should be treated similarly.

Nevertheless, here is a quote from the press release.

"Recognizing the painful, isolated lives experienced by patients with CAPS, we are pleased that we can offer these patients an FDA-approved therapy that helps control its debilitating symptoms," said Leonard S. Schleifer, M.D., Ph.D., Regeneron's president and chief executive officer.

Zz - just saying
Print the post Back To Top
No. of Recommendations: 0
Hey Double Z,

That's hilarious. Great find.

Fool On,
Print the post Back To Top